上海复星医药2005年半年度报告（节录）_医药资讯

财务资料1、主要会计数据及财务指标单位:元 币种:人民币主要会计数据本报告期末上年度期末本报告期末比上年度期末增减（％）流动资产1,942,454,986.321,779,685,185.319.15流动负债1,683,866,953.091,594,026,825.425.64总资产5,522,431,368.855,170,502,559.876.81股东权益（不含少数股东权益）2,352,552,119.062,304,105,035.772.10每股净资产2.832.7881.51调整后的每股净资产2.762.766-0.22报告期（1－6月）上年同期本报告期比上年同期增减（％）净利润121,281,131.42122,329,747.59-0.86扣除非经常性损益后的净利润91,044,228.81118,367,637.94-23.08每股收益0.1460.150-2.67净资产收益率（%）5.165.68减少0.52个百分点经营活动产生的现金流量净额108,587,110.36118,662,122.93-8.492、扣除非经常性损益项目和金额单位:元 币种:人民币非经常性损益项目金额处置除公司产品外的其他资产产生的损益29,186,049.56各种形式的政府补贴1,375,359.03扣除资产减值准备后的其他各项营业外收入、支出-324,505.98合计30,236,902.613、净资产收益率及每股收益单位:元 币种:人民币报告期利润净资产收益率（%）每股收益全面摊薄加权平均全面摊薄加权平均主营业务利润19.5719.320.2470.247营业利润3.983.920.1120.113净利润5.165.090.1460.146扣除非经常性损益后的净利润3.873.820.1090.1104、利润及利润分配表单位:元 币种:人民币项 目合并母公司本期数上年同期数本期数上年同期数一、主营业务收入1,466,872,649.111,283,469,150.717,173,277.403,388,652.80减：主营业务成本998,154,170.43897,509,219.787,011,854.993,362,603.25主营业务税金及附加8,280,244.347,835,215.160.00480,009.88二、主营业务利润（亏损以“-”号填列）460,438,234.34378,124,715.77161,422.41-453,960.33加：其他业务利润（亏损以“-”号填列）23,167,959.4716,786,403.577,208,700.135,451,378.84减:营业费用216,188,471.46164,619,866.480.000.00管理费用157,259,175.05143,015,961.5615,387,113.5311,988,757.81财务费用16,645,296.368,448,955.3514,531,320.006,050,684.17三、营业利润（亏损以“-”号填列）93,513,250.9478,826,335.95-22,548,310.99-13,042,023.47加：投资收益（损失以“-”号填列）76,162,483.3993,840,051.44143,829,442.41133,429,837.61补贴收入1,618,069.454,731,715.100.000.00营业外收入34,684,988.811,339,583.710.000.00减：营业外支出730,231.661,409,993.340.0025,977.09四、利润总额（亏损总额以“-”号填列）205,248,560.93177,327,692.86121,281,131.42120,361,837.05减：所得税28,408,216.2616,101,060.010.00-1,967,910.54减：少数股东损益55,578,207.5538,896,885.260.000.00加：未确认投资损失(合并报表填列)18,994.300.000.000.00五、净利润（亏损以“-”号填列）121,281,131.42122,329,747.59121,281,131.42122,329,747.59加：年初未分配利润411,289,266.38372,496,898.23569,584,025.29477,524,670.98其他转入六、可供分配的利润532,570,397.80494,826,645.82690,865,156.71599,854,418.57减：提取法定盈余公积提取法定公益金提取职工奖励及福利基金(合并报表填列)提取储备基金提取企业发展基金利润归还投资七、可供股东分配的利润532,570,397.80494,826,645.82690,865,156.71599,854,418.57减：应付优先股股利0.000.00提取任意盈余公积0.000.00应付普通股股利124,792,364.2981,782,465.80124,792,364.2981,782,465.80转作股本的普通股股利0.000.00八、未分配利润(未弥补亏损以“-”号填列)407,778,033.51413,044,180.02566,072,792.42518,071,952.77补充资料：1.出售、处置部门或被投资单位所得收益2.自然灾害发生的损失3.会计政策变更增加(或减少)利润总额4.会计估计变更增加(或减少)利润总额5.债务重组损失6.其他 详见《上海复星医药（集团）股份有限公司2005年半年度报告》（据“上海证券交易所”；医药网整理，严禁转载） 医药网新闻